Becton, Dickinson and Company announced that Dr. Joseph M. Smith has been named senior vice president and chief scientific officer for the company, effective November 29, 2021. In this role, Smith will be primarily responsible for external innovation and the company?s technology roadmap to deliver transformative innovations that align to three irreversible forces driving the future of health care: smart connected care, the transition to new care settings and chronic disease. Smith will lead a reinvigorated focus on external technology partnerships and oversee the development of new innovation models. Smith will also establish and co-chair the company?s Scientific Advisory Board (SAB), which will be comprised of top external medical key opinion leaders, science and technology experts and experienced innovation leaders. Smith reports to Elizabeth McCombs, executive vice president and chief technology officer for the company. Smith joins the company from Digital Health Corp, where he served as president and CEO. He also served as president for a digital transformation consultancy, providing business, technology and clinical insight to medical device and diagnostics companies. During his career, Smith has held medical, scientific and technology leadership positions at multiple organizations including Johnson & Johnson, Boston Scientific and the West Health Institute. Smith is a member of the board of directors at four, private companies including Constant Therapy Health, Inc; EP Sciences Inc.; PDS Inc.; and Ocudyne Inc.